Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 26, 2024; 12(15): 2499-2505
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2499
Recent trends in bone metastasis treatments: A historical comparison using the new Katagiri score system
Kenji Matsuda, Kazuhiro Shimazu, Hanae Shinozaki, Koji Fukuda, Taichi Yoshida, Daiki Taguchi, Kyoko Nomura, Hiroyuki Shibata
Kenji Matsuda, Kazuhiro Shimazu, Hanae Shinozaki, Koji Fukuda, Taichi Yoshida, Daiki Taguchi, Hiroyuki Shibata, Department of Clinical Oncology, Akita University Graduate School of Medicine, Akita 010-8543, Japan
Kyoko Nomura, Department of Environmental Health Science and Public Health, Akita University Graduate School of Medicine, Akita 010-8543, Japan
Hiroyuki Shibata, Department of Comprehensive Cancer Control, Akita University Graduate School of Medicine, Akita 010-8543, Japan
Co-first authors: Kenji Matsuda and Kazuhiro Shimazu.
Author contributions: Matsuda K and Shimazu K contributed equally to this work as co-first authors; Matsuda K, Shimazu K, Shinozaki H, Fukuda K, Yoshida T, Taguchi D and Shibata H treated the patients; Matsuda K and Shimazu K collected and analyzed the data; Nomura K confirmed the statistical analyses; Shibata H overviewed this study and prepared the manuscript.
Institutional review board statement: This study was certified and approved by the Ethics Committees of Akita University (No. 2814).
Informed consent statement: Written informed Consent for Publication of case could not be obtained from all participants. Instead, notification about the purpose and the implementation of the research was made public and an "opt-out" system was implemented to guarantee the opportunity to refuse as much as possible.
Conflict-of-interest statement: No author has any conflict of interest concerning this publication.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Hiroyuki Shibata, MD, PhD, Professor, Department of Clinical Oncology, Akita University Graduate School of Medicine, Hondo 1-1-1, Akita 010-8543, Japan. hiroyuki@med.akita-u.ac.jp
Received: December 10, 2023
Revised: April 6, 2024
Accepted: April 15, 2024
Published online: May 26, 2024
Processing time: 155 Days and 20.4 Hours
Core Tip

Core Tip: We investigated bone metastasis patients from 2012 to 2023 at Department of Clinical Oncology, Akita University Hospital to learn about recent trends in treatment methods and outcomes for patients with bone metastases. The prognosis of patients with bone metastases has improved recently. Now, there is a room for surgical interventions to the patients with bone metastases, which have been avoided due to their limited prognosis. These are expected to improve activities of daily living and quality of life and will benefit patients. Accordingly, guidelines and scoring system for prognosis need to be revised.